Koninklijke Philips (NYSE:PHG) Announces Earnings Results

Koninklijke Philips (NYSE:PHG) posted its quarterly earnings data on Wednesday. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01), Zacks reports. The business had revenue of $5.38 billion for the quarter, compared to analysts’ expectations of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.94% and a negative net margin of 3.88%.

Koninklijke Philips Stock Performance

Koninklijke Philips stock opened at $25.04 on Friday. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60. Koninklijke Philips has a 12 month low of $19.55 and a 12 month high of $32.91. The company has a fifty day moving average price of $26.25 and a two-hundred day moving average price of $28.16.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on PHG. Jefferies Financial Group upgraded shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. UBS Group raised shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday. Finally, StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Thursday. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Koninklijke Philips presently has an average rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.